Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This position will be responsible for independent programming and verification of Clinical Trial Data to produce high quality deliverables to consistently meet study timelines, quality standards and requirements. This person will be required to work closely and communicate effectively with internal team members, Statisticians, and other functional group members to best serve the deliverable need.